Trypanocidal Drugs [phsu]
Chronic infection [dsyn]
Asymptomatic [fndg]
Trypanosoma cruzi [euka]
Background [cnce]
Prevention [topp]
chronic [tmco]
Cardiomyopathy [dsyn]
treating [topp]
Infected [ftcn]
Population [qnco]
therapy [ftcn]
Challenge [clna]
Enthusiasm [menp]
therapy [ftcn]
Uncertainty [idcn]
Efficacy [qlco]
Concern [idcn]
Safety [hcpp]
Limited [ftcn]
Availability [ftcn]
BARRIER [medd]
Wide [spco]
Conventional [qlco]
Drug [phsu]
Update [tmco]
Previous [tmco]
Version [ftcn]
Review [inpr]
objectives [inpr]
To [qlco]
search [inpr]
Extract [sbst]
Data [idcn]
eligible [idcn]
studies [lbpr]
Compare [acty]
Outcome [ftcn]
cohorts [popg]
Seropositive [qlco]
Individual [popg]
Trypanosoma cruzi [euka]
Exposed [clna]
therapy [ftcn]
placebo [topp]
treatment [ftcn]
search [inpr]
Methods [inpr]
eligible [idcn]
studies [lbpr]
Database, Electronic [inpr]
Central [spco]
Controlled [ftcn]
Trial [resa]
Issue [fndg]
MEDLINE [inpr]
ovid [mamm]
ovid [mamm]
lilacs [plnt]
Combine [mnob]
Term [tmco]
Disease [dsyn]
treatment [ftcn]
search [inpr]
included [ftcn]
search [inpr]
Reference [idcn]
Review [inpr]
Select [acty]
Article [inpr]
search [inpr]
File [ocac]
Applied [hlca]
Language [lang]
Restriction [ftcn]
Selection Criteria [qlco]
Review [inpr]
Authors [prog]
screen [hlca]
Reference [idcn]
Eligibility [hlca]
Human [humn]
participants [popg]
treated [topp]
therapy [ftcn]
Then [tmco]
Assessed [acty]
Pre [tmco]
Select [acty]
studies [lbpr]
Full [qlco]
Inclusion [qlco]
included [ftcn]
Controlled [ftcn]
Trial [resa]
OBSERVATIONAL [resa]
Study [mnob]
Provided [acty]
Data [idcn]
Mortality [qnco]
Clinical [qlco]
progression [patf]
chronic [tmco]
Cardiomyopathy [dsyn]
Four [qnco]
Follow-up [fndg]
Data Collection [resa]
Analysis [lbpr]
Team [grup]
Two [qnco]
Review [inpr]
Authors [prog]
carried [acty]
Out [spco]
Study [mnob]
Data Extraction [resa]
Risk [qlco]
Bias [idcn]
Assessment [hlca]
resolving [idcn]
Disagreement [socb]
Pair [qlco]
Data Collection [resa]
included [ftcn]
Study Design [resa]
Characteristics [qlco]
Population [qnco]
interventions [hlca]
exposures [inpo]
Outcome Measures [qnco]
Defined [cnce]
Categories [inpr]
Outcome [ftcn]
Data [idcn]
Parasite [euka]
positive serology [lbtr]
Xenodiagnosis [diap]
Polymerase Chain Reaction [lbpr, mbrt]
therapy [ftcn]
Participant [popg]
Including [ftcn]
Efficacy [qlco]
Outcome [ftcn]
progression [patf]
chronic [tmco]
Cardiomyopathy [dsyn]
Mortality [qnco]
side effects [ftcn]
therapy [ftcn]
Reported [inpr]
Pooled [cnce]
Outcome [ftcn]
Data [idcn]
Odds Ratios [qnco]
Mean [qnco]
Confidence Intervals [qnco]
Using [ftcn]
RANDOM [resa]
Effect [qlco]
Model [inpr]
I- [inch]
Statistics [ocdi]
Provided [acty]
Estimate [qnco]
Heterogeneity [qlco]
studies [lbpr]
Conduct [inbe]
Meta-Analysis [inpr]
Regression [patf]
Relationship [qlco]
positive serology [lbtr]
progression [patf]
chronic [tmco]
Cardiomyopathy [dsyn]
Mortality [qnco]
Main [qlco]
Result [ftcn]
included [ftcn]
studies [lbpr]
Involving [ftcn]
participants [popg]
Six [qnco]
Controlled [ftcn]
Trial [resa]
N NOS [aapp, imft]
Five [qnco]
Controlled [ftcn]
Trial [resa]
Intermediate Risk [cnce]
Bias [idcn]
One [qnco]
High Risk [qlco]
Bias [idcn]
Four [qnco]
Non [ftcn]
experiments [resa]
N NOS [aapp, imft]
Three [qnco]
Observational Study [resa]
N NOS [aapp, imft]
TEN [dsyn]
Study [mnob]
test drug [lbpr]
Nifurtimox [orch, phsu]
BENZNIDAZOLE [orch, phsu]
Three [qnco]
Exposed [clna]
participants [popg]
Allopurinol [orch, phsu]
One [qnco]
Itraconazole [orch, phsu]
Five [qnco]
studies [lbpr]
Conduct [inbe]
Brazil [geoa]
Five [qnco]
Argentina [geoa]
One [qnco]
Bolivia [geoa]
One [qnco]
Chile [geoa]
One [qnco]
Venezuela [geoa]
therapy [ftcn]
Associated [qlco]
Heterogeneous [qlco]
reductions [npop]
Parasite [euka]
Outcome [ftcn]
positive serology [lbtr]
studies [lbpr]
Odds Ratios [qnco]
Confidence Intervals [qnco]
I- [inch]
Polymerase Chain Reaction [lbpr, mbrt]
studies [lbpr]
Odds Ratios [qnco]
Confidence Intervals [qnco]
I- [inch]
Xenodiagnosis [diap]
treatment [ftcn]
studies [lbpr]
Odds Ratios [qnco]
Confidence Intervals [qnco]
I- [inch]
reduction [npop]
antibody titres [lbpr]
studies [lbpr]
Mean [qnco]
Confidence Intervals [qnco]
I- [inch]
Efficacy [qlco]
Data [idcn]
Patient Outcome [idcn]
Non [ftcn]
Controlled [ftcn]
Trial [resa]
therapy [ftcn]
Associated [qlco]
IMPRECISION [phpr]
Inconsistent [qlco]
reductions [npop]
progression [patf]
chronic [tmco]
Cardiomyopathy [dsyn]
studies [lbpr]
Events [evnt]
Odds Ratios [qnco]
Confidence Intervals [qnco]
I- [inch]
Mortality [qnco]
therapy [ftcn]
studies [lbpr]
Events [evnt]
Odds Ratios [qnco]
Confidence Intervals [qnco]
I- [inch]
Overall [inpr]
median [spco]
Incidence [qnco]
Severe [qlco]
side effects [ftcn]
Individual [popg]
Five [qnco]
studies [lbpr]
Exposed [clna]
therapy [ftcn]
Overall [inpr]
Discontinuation [hlca]
Two [qnco]
month [tmco]
therapy [ftcn]
Controlled [ftcn]
Trial [resa]
studies [lbpr]
Events [evnt]
Control [grup]
Five [qnco]
studies [lbpr]
Events [evnt]
Authors [prog]
Conclusions [idcn]
Evidence [ftcn]
therapy [ftcn]
Reduced [qlco]
Parasite [euka]
Outcome [ftcn]
low [qlco]
Quality [qlco]
Inconsistent [qlco]
Data [idcn]
Patient Outcome [idcn]
treated [topp]
More [ftcn]
Diverse [qlco]
Controlled [ftcn]
Trial [resa]
Testing [ftcn]
New [tmco]
forms [qlco]
therapy [ftcn]
Order [inpr]
Estimate [qnco]
Efficacy [qlco]
Factor [ftcn]
Responsible [fndg]
Heterogeneity [qlco]
Result [ftcn]
Increase [ftcn]
Knowledge [inpr]
Efficacy [qlco]
Tolerance [fndg]
Balance [orgf]
Conventional Therapy [topp]
